GLAXO SEEKS EUROPEAN OK FOR ITS BREAST CANCER DRUG

GlaxoSmithKline PLC said it is seeking regulatory approval to sell its breast cancer drug Tykerb -- one of the most promising high earners in its pipeline of new medicines -- in Europe. Boston Globe (http://www.boston.com/business/globe/articles/2006/10/10/glaxo_seeks_european_ok_for_its_breast_cancer_drug/)